I tch is a frequent symptom of many ocular conditions, including allergic conjunctivitis, dry eye and microbial infections 1-3 . Ocular itch, especially that induced by severe ocular allergy such as atopic or vernal keratoconjunctivitis, is often difficult to manage 1,2,4 . Compulsive rubbing or scratching itchy eyes may result in ocular infections or injuries, keratoconus and even cataracts 5,6 . Ocular itch mainly occurs in the conjunctiva, the mucosal membrane lining the inside of the upper and lower eyelids and covering the sclera 2,4 . By contrast, itch is usually absent from the cornea. It is perplexing why itch occurs in the conjunctiva rather than the cornea. Unlike the conjunctiva, the cornea lacks blood vessels and mature immune cells and is immune-privileged 7,8 . Because the interaction between immune cells and sensory neurons plays an essential role in many types of chronic itch 9,10 , the absence of immune cells may underlie the lack of itch in the cornea. However, studies have shown that compounds released from immune cells, such as histamine, are found in the tear fluids, which lubricate the cornea as well as the conjunctiva 11,12 ; therefore, sensory fibers in the cornea can readily interact with these compounds. The mechanism underlying the conjunctival origin of ocular itch remains unclear.
hypothesize that the selective origins of ocular itch and nociception are due to differences in sensory fibers innervation of the cornea and conjunctiva.
Our previous study has revealed the essential involvement of a transient receptor potential cation channel, subfamily A, member 1 (TRPA1)-mediated nonhistaminergic itch pathway in allergic ocular itch 18 . However, TRPA1 is expressed by both nociceptive and itch-sensing neurons 19, 20 . It is unknown which subsets of TRPA1 + sensory neurons are critical for ocular itch, and their innervation patterns in the conjunctiva and cornea are also uncertain. Recent large-scale single-cell RNA sequencing has classified three discrete populations of dorsal root ganglion (DRG) neurons with distinct repertories of itch receptors 21 . The first population is defined by the expression of itch receptors for β -alanine (MAS-related G protein-coupled receptor member D (MrgprD)) and lysophosphatidic acid (lysophosphatidic acid receptor 3 (LPAR3) and LPAR5). This population mediates mechanical pain 22 and skin itch induced by β -alanine and cholestasis associated with elevated levels of lysophosphatidic acid 21, 23, 24 . The second population is specifically linked to skin itch. These neurons express the itch receptors MrgprA3, MrgprC11 and MrgprX1 and detect multiple pruritogens, including the itch-inducing peptides BAM8-22 and SLIGRL, the antimalaria drug chloroquine and cathepsin S 21, [25] [26] [27] [28] [29] . The third population expresses neuropeptide somatostatin (SST) and itch receptors for interleukin (IL)-31, leukotriene D4 (LTD4) and serotonin, and it mediates skin itch induced by these pruritogens 21, 30 . In addition to itch-sensing neurons, single-cell RNA sequencing also revealed two types of peptidergic nociceptive neurons and type C low-threshold mechanoreceptors (C-LTMRs) that are involved in mechanical pain Articles NATUre MedIcINe and pleasant touch 21, 31 . However, it is unclear whether this proposed classification of sensory fibers for DRG neurons also applies to ocular afferents and whether the selective origins of ocular itch and nociception are attributed to distinct sensory innervation patterns of the cornea and conjunctiva. To address these questions, an indepth classification of primary sensory neurons, axonal projection and functional characterization of each population in the cornea and conjunctiva are therefore required.
results
Distinct sensory innervation patterns between the cornea and conjunctiva. Both the conjunctiva and cornea receive axonal innervation from primary sensory neurons located in the trigeminal ganglia (TG). As determined on the basis of gene expression profiles, ocular afferent neurons are heterogeneous and can be grouped into multiple subsets according to the molecular criteria used for classification of DRG neurons 21 ( Supplementary Table 1 ). We found that in mice, conjunctiva and cornea as well as skin are innervated by most populations of sensory neurons, including TRPV1 + heat-sensitive neurons and neuropeptide calcitonin gene-related peptide (CGRP)-expressing nociceptive neurons (Supplementary Table 2 ). However, low-threshold mechanosensitive C fiber neurons that express vesicular glutamate transporter 3 (VGLUT3, gene Slc17a8) 31, 32 selectively innervate the whole-mount cornea but not the conjunctiva (Fig. 1a-c and Supplementary Table 2 ). This selective innervation pattern was further confirmed by section staining and retrograde tracing ( Supplementary Fig. 1 ). In addition, we found that cold-sensing transient receptor potential cation channel subfamily M, member 8 (TRPM8) + sensory fibers branch extensively and terminate in the superficial layers of the corneal epithelium, but only very few TRPM8 + primary afferent fibers were found in the palpebral conjunctiva ( Fig. 1d-f , Supplementary Fig. 2 and Supplementary Table 2 ).
Finally, among the nine populations examined, two populations of primary sensory neurons were discovered that selectively innervate the conjunctiva but not the cornea ( Fig. 1 and Supplementary  Table 2 ). The first population specifically expresses MrgprD. Using an Mrgprd eGFP/+ reporter line 33 , we found that MrgprD + sensory fibers innervate the conjunctiva but not the cornea ( Fig. 1g -i). Dissimilar to their broad innervation in the skin, MrgprD + sensory fibers merely innervate the marginal conjunctiva ( Fig. 1g,h ). This region contacts with the ocular surface during blinking and is termed the lid wiper 34 .
The second population expresses MrgprA3. Using Mrgpra3 GFP-cre ; Rosa26 tdTomato/+ (Mrgpra3 tdTomato ) mice 26 , we found that MrgprA3 + sensory fibers selectively innervate the conjunctiva but are completely absent from the cornea and tested mucosal tissues, including nasal and oral mucosa, rectum and vagina ( Fig. 1j-o ). MrgprA3 + sensory terminals are particularly enriched in the conjunctiva close to the medial and lateral canthi (corners of the eye), regions that are most sensitive to itch. This selective innervation pattern was further confirmed by retrograde tracing ( Supplementary Fig. 3 ), suggesting a role for MrgprA3 + sensory fibers in ocular itch. The other population of itch-related sensory neurons that express SST is completely absent from both the conjunctiva and cornea ( Fig. 1p-r) , despite their dense innervation in the skin (Fig. 1r ). Distinct sensory innervation patterns of the cornea and conjunctiva were further confirmed by single-cell RT-PCR ( Fig. 1s and Supplementary Table 1 ).
A subset of conjunctival-selective sensory fibers mediates ocular itch.
To test the hypothesis that ocular itch is mediated by conjunctiva-selective sensory fibers, we studied the function of corneal-or conjunctival-selective sensory neurons in ocular itch. We first examined the involvement of corneal TRPM8 + sensory fibers in ocular itch. Exposing mouse eyes to cold air flow (13 °C) or menthol (an organic compound from peppermint that selectively 
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activates TRPM8) provokes pain-related blinking and eye-closing responses, rather than itch-related scratching behavior, in wild-type (WT) mice. TRPM8-deficiency entirely abolished pain responses to cold stimuli ( Supplementary Fig. 4 ), indicating that TRPM8 mediates corneal cold supersensitivity. To further study the function of conjunctival-selective sensory fibers in ocular sensation, we topically applied itch-or pain-inducing chemicals to the lower conjunctival sac in mice 18 . We discovered that IL-31 and LTD4, two immune factors that selectively activate SST + sensory neurons in the skin 21 , failed to generate ocular itchrelated scratching or pain-related wiping behavior in mice ( Fig. 2a ), corroborating the absence of SST + sensory fibers in the conjunctiva. As a control, IL-31 evokes remarkable itch in the skin ( Fig. 2a ), as reported previously 21, 30, 35 . Next, we examined the role of MrgprD + neurons in ocular sensation. Using β -alanine (a MrgprD agonist) as a stimulant, we found that activation of MrgprD + neurons only evoked minimal ocular scratching ( Fig. 2b) , providing evidence against an important role for these neurons in ocular itch. The fact that the innervation of MrgprD + neurons is restricted to the lid wiper region of the conjunctiva (Fig. 1g ,h) supports the notion that these neurons sense eye blinking and tearing rather than itch.
Finally, we tested the role of MrgprA3 + neurons in ocular itch. We found that ablation of MrgprA3 + sensory neurons ( Supplementary  Fig. 5 ) significantly reduces ocular itch induced by an array of itchinducing molecules. Chloroquine, the agonist for MrgprA3 25 , elicits significant ocular itch in WT mice, but not in MrgprA3 + neuronablated mice (Fig. 2c ). In addition, neuropeptide FF (NPFF), an agonist for itch receptor MrgprC11 36 , also induces ocular itch in an Mrgpr-dependent manner. Ocular itch induced by histamine and serotonin is abolished in MrgprA3 + neuron-ablated mice as well ( Fig. 2c ). This result is entirely unexpected, as histamine and serotonin can activate MrgprA3-independent itch-sensing fibers in the skin, and ablation of MrgprA3 + neurons cannot completely abolish the skin itch induced by these pruritogens 21, 26, 30, 37 . Our results demonstrate that the underlying mechanisms involved in ocular itch and skin itch are different and that MrgprA3 + sensory neurons play a more predominant role in ocular itch than in skin itch.
We further characterized the physiological properties of MrgprA3 + neurons that innervate the conjunctiva by crossing MrgprA3 tdTomato mice with Pirt GCaMP3/+ mice expressing the calcium indicator GCaMP3 in primary sensory neurons 38 . The resulting Pirt GCaMP3/+ ; Mrgpra3 tdTomato mouse line allows ex vivo imaging of calcium mobilization in MrgprA3 + sensory fibers (labeled by tdTomato) in response to pruritogens applied onto the conjunctiva ( Fig. 2d-i and Supplementary Fig. 6 ). Indeed, we discovered that MrgprA3 + fibers respond to a range of itch-inducing chemicals with an increased concentration of intracellular Ca 2+ ([Ca 2+ ] i ), including histamine, serotonin, chloroquine and NPFF ( Fig. 2d-i and Supplementary Fig. 6 ), correlating well with our in vivo behavioral results. Notably, MrgprA3 + sensory neurons innervating body skin failed to respond to serotonin ( Supplementary Fig. 7 ). Instead, MrgprA3-independent SST + sensory neurons mediate serotonininduced itch in the skin 30 . Our results thus support that MrgprA3 + sensory fibers in the conjunctiva incorporate a partial function of SST + sensory neurons and are different from those innervating the skin ( Fig. 2j ), providing a molecular basis for the predominant role of MrgprA3 + sensory neurons in ocular itch. Interestingly, histamine, serotonin and NPFF have been reported to be secreted from mast cells 36, 39, 40 , suggesting that conjunctival MrgprA3 + sensory neurons might detect itch mediators from mast cells in allergy and mediate ocular itch associated with allergic conjunctivitis (Fig. 2j ). Indeed, conjunctival allergen challenge elicited significant degranulation of mast cells and scratching behavior directed to the treated eye in immunized WT mice ( Fig. 3a-c) . Notably, we found that mast cells are closely associated with MrgprA3 + sensory fibers in the conjunctiva (Fig. 3d,e ). Upon degranulation of a mast cell, granules directly interact with MrgprA3 + sensory fibers ( Fig. 3f ). Ablation of MrgprA3 + neurons significantly reduced allergic ocular itch ( Fig. 3g ), indicating that MrgprA3 + sensory fibers are the principal itch-sensing fibers for inflammatory mediators released by conjunctival mast cells in this allergic conjunctivitis model.
The central neural circuit for ocular itch.
Studies have revealed distinct central representations for sensory fibers innervating either the conjunctiva or cornea 41 . However, it is unclear whether this anatomical difference underlies the conjunctival origin of ocular itch and corneal insensitivity to itch. Neuromedin B (NMB) is a bombesin-related peptide and is highly expressed in small-diameter sensory neurons, including MrgprA3 + neurons 42, 43 . Its function in pain and itch, however, remains controversial 42, 44 . Interestingly, we found that NMB is highly expressed in the sensory neurons innervating the conjunctiva but not the cornea ( Fig. 4a-g) . Importantly, Nmb-null mice display significantly reduced ocular itch ( Fig. 4i ) but normal responses to ocular pain, suggesting that NMB is required for transmission of the itch signal from ocular afferent fibers. Furthermore, NMBR, the receptor for NMB, is found in the central projection area of sensory fibers innervating the conjunctiva as well as the neighboring area that may receive sensory inputs from the skin sensory fibers (such as those from the eyelid skin) ( Fig. 4j ). However, NMBR is completely absent from the central projection area of the cornea (Fig. 4h ). Similar to NMB deficiency, deletion of NMBR leads to a significant reduction in ocular itch (Fig. 4i ).
These results indicate that NMB-NMBR signaling is required for conjunctival itch transmission, providing a new central mechanism explaining why the cornea is not 'itch' sensitive.
Development of a new therapeutic strategy for allergic ocular itch.
To test whether selective silencing of MrgprA3 + sensory fibers using pharmacological approaches is a feasible therapeutic strategy to provide sustained relief of ocular itch, we adopted an approach 
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NATUre MedIcINe of reversibly silencing MrgprA3 + fibers by targeted delivery of a charged sodium-channel blocker, QX-314. QX-314 is membraneimpermeable and can only enter the cell through large pores of ion channels opened upon neuronal excitation 45, 46 . Because TRPA1 is the downstream transduction channel of MrgprA3 (ref. 20 , QX-314 would be able to permeate into MrgprA3 + neurons via the opening of TRPA1 upon chloroquine challenge ( Supplementary Fig. 8a ). Indeed, using Mrgpra3 tdTomato mice, we confirmed that chloroquinemediated activation of TRPA1 channels allows sufficient QX-314 uptake to suppress voltage-dependent inward sodium currents in MrgprA3 + neurons ( Supplementary Fig. 8b-e ). This reduction in sodium currents was sufficient to suppress the generation of action potentials in MrgprA3 + neurons ( Fig. 5a-d ). Furthermore, application of a low concentration of chloroquine (4 mM; Supplementary  Fig. 9 ) and QX-314 (1%, 2 μ l) onto the conjunctiva effectively suppressed the subsequent ocular itch induced by chloroquine (12 mM) applied 30 min later ( Fig. 5e ), suggesting that conjunctival MrgprA3 + sensory fibers can be silenced in vivo. Importantly, this pretreatment of QX-314 with chloroquine remarkably alleviated allergic ocular itch in mice for more than 24 h, and its efficacy diminished through the next 24 h (Fig. 5f ). In contrast, the antiitch effects of an antihistamine, pheniramine, diminished within 1 h ( Fig. 5g ). Thus, selective silencing of MrgprA3 + sensory fibers provides more potent and sustained relief of allergic ocular itch than the conventional antihistamine ( Fig. 5h ). We next examined the effects of silencing itch-sensing fibers on migration and infiltration and activation of immune cells (particularly mast cells). Allergen challenge induces extensive mast cell accumulation and degranulation ( Fig. 5i-k) . Silencing of MrgprA3 + sensory fibers effectively diminished mast cell accumulation (Fig. 5i-j) but did not reduce mast cell degranulation. In contrast, pheniramine did not affect mast cell accumulation or immune cell infiltration ( Fig. 5i-k) . To investigate the mechanisms underlying the immune regulatory effect of silencing itch-sensing afferent fibers, we tested whether MrgprA3 + sensory neurons produce neuropeptides capable of attracting immune cells. Although substance P can directly activate mast cells 47, 48 , it was not expressed in MrgprA3 + neurons ( Supplementary Fig. 10 ), consistent with our single-cell . Statistical analysis by one-way ANOVA followed by two tailed Student's t-test (Nmb −/− versus WT, ***P = 0.000002; Nmbr −/− versus WT, ***P = 0.00004). All data are expressed as mean ± s.e.m.
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qRT-PCR results ( Supplementary Table 1 ) and previous findings 26 .
In contrast, we detected the expression of neuropeptide CGRP in MrgprA3 + neurons (Fig. 5l ). The administration of CGRP peptide into the mouse conjunctiva sac unexpectedly recruited more mast cells but did not cause mast cell degranulation or itch (Fig. 6m,n) .
Conserved innervation pattern and function of itch-sensing afferent fibers in human conjunctiva. Our finding of mouse MrgprA3 + sensory fibers in ocular itch raises the question of whether human Mrgpr (hMrgpr)-expressing sensory fibers play a similar role in itch perception. Among all the human Mrgprs, hMrgprX1 is sensitive to chloroquine and corresponds to mouse MrgprA3 (ref. 25 ). Hence, we examined the innervation pattern of hMrgprX1 + sensory fibers in the eye using a newly generated anti-hMrgprX1 antibody. The antibody selectively stained sensory neurons of MRGPRX1; Mrgpr-clusterΔ −/− mice, in which hMrgprX1, instead of mouse Mrgprs, is expressed in mouse sensory neurons, but not those from Mrgpr-clusterΔ −/− mice (Fig. 6a,b) , indicating that the antibody specifically recognizes hMrgprX1. Using this antibody, we found that hMrgprX1 + sensory fibers selectively innervate the conjunctiva but not the cornea of human eyes (Fig. 6c,d) , correlating well with the innervation pattern of itch-sensing fibers in mice.
To determine whether the activation of hMrgprX1 allows the entry of QX-314 via TRPA1 channels, we examined whether TRPA1 is the downstream transduction channel of hMrgprX1 in TG sensory neurons from MRGPRX1; Mrgpr-clusterΔ −/− mice. We found that the chloroquine triggered a train of action potentials in hMrgprX1-expressing sensory neurons (identified by calcium imaging; Fig. 6e,f) . Importantly, pretreatment with TRPA1 antagonist HC030031 effectively suppressed the neuronal discharge in response to chloroquine (Fig. 6e,f) , indicating that TRPA1 is the downstream transduction channel of hMrgprX1 and is required for 
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NATUre MedIcINe the depolarization of hMrgprX1 + neurons. We further examined the feasibility of selectively silencing hMrgprX1 + sensory fibers using QX-314 for itch treatment. We found that neuronal silencing is effective in alleviating allergic ocular itch in MRGPRX1; Mrgpr-clusterΔ −/− mice (Fig. 6g) . The anti-itch effect lasts for at least 24 h in this humanized mouse model (Fig. 6g) . Importantly, QX-314mediated neuronal silencing is ineffective in Mrgpr-clusterΔ −/− mice (Fig. 6g ) because of a lack of Mrgprs required for chloroquinemediated entry of QX-314 into ocular itch fibers, demonstrating the specificity of this neuronal silencing approach. Notably, deficiency in Mrgprs considerably reduces ocular itch in Mrgpr-clusterΔ −/− mice, suggesting an indispensable role for Mrgprs in mediating ocular itch. This itch defect can be entirely rescued by the expression of hMrgprX1 in MRGPRX1; Mrgpr-clusterΔ −/− mice (Fig. 6g) , indicating that hMrgprX1 mediates ocular itch and provides a new drug target for ocular itch. To understand the mechanism through which hMrgprX1 mediates allergic ocular itch, we examined whether hMrgprX1 can be activated by itch mediators released from mast cells in allergy. Our previous study shows that NPFF can be released from mast cells and activate sensory neurons via mouse MrgprC11 (ref. 36 ). Here, we found that NPFF also activates hMrgprX1, as revealed by calcium imaging (Fig. 6h) . Importantly, NPFF induces significant ocular itch in a manner dependent on mouse Mrgpr or hMrgprX1 (Fig. 6i) . These data suggest that hMrgprX1 is capable of detecting itch mediators (such as NPFF) released from mast cells, providing one of the mechanisms through which hMrgprX1 mediates allergic ocular itch. Together, our results indicate that hMrgprX1 is a principal itch receptor for ocular itch and hence a promising drug target for itch management.
Discussion
The findings of conjunctiva-and cornea-selective sensory innervations substantially advance our understanding of the neural basis underlying the dichotomy of ocular itch and pain. The conjunctiva plays an important role in immune surveillance and helps prevent the entrance of microbes into the eye. The selective projection of itch-sensing fibers to the conjunctiva enables the peripheral sensory system to monitor immune homeostasis and initiate an alarm when the immune system is dysregulated. Indeed, itch is closely associated with many types of immune disorders in the conjunctiva, including allergy, infection and inflammation. By contrast, to maintain its transparency for refracting light and focusing our vision, the cornea lacks blood vessels and is immune privileged 7, 8 . Hence, the immune surveillance function of itch-sensing fibers is not required for the cornea. Moreover, (e) or that in reverse order (f). g, Scratching responses induced by conjunctiva challenge with allergen ovalbumin in immunized WT, Mrgpr-clusterΔ −/− and MRGPRX1; Mrgpr-clusterΔ −/− mice with or without pretreatments of 1% QX-314 with 4 mM chloroquine (30 min; n = 6 and 3 (WT group), 5 and 6 (KO group), 6 and 7 (X1 group); 24 h, n = 3 and 3 (WT group), 4 and 6 (KO group), 6 and 7 (X1 group)). Statistical analysis by two-tailed Student's t-test (WT versus WT/QX314: 30 min *P = 0.011, 24 h *P = 0.03; X1 versus X1/QX314: 30 min ***P = 0.0007, 24 h **P = 0.007). h, Representative calcium transients of hMrgprX1-expressing heterologous cells in response to NPFF (6 μ M) and BAM8-22 (2 μ M). In the inset, arrows indicate BAM8-22responsive hMrgprX1-expressing cells that were activated by NPFF. i, Scratching responses induced by conjunctival application of NPFF (2.5 nmol in 2.5 μ l) in WT (n = 5), Mrgpr-clusterΔ −/− (n = 6) and MRGPRX1; Mrgpr-clusterΔ −/− mice (n = 6). Statistical analysis by one-way ANOVA (P = 0.0082) followed by two-tailed Student's t-test (WT versus KO, *P = 0.016; KO versus X1, ***P = 0.0001). All data are expressed as mean ± s.e.m.
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NATUre MedIcINe the cornea is very fragile and easily damaged. Studies have shown that chronic eye rubbing causes corneal thinning and keratoconus, a condition in which the shape of the cornea becomes irregular or conical. As a protective mechanism, the cornea is densely innervated by subsets of primary sensory fibers and generates pain in response to normally innocuous stimuli. Our finding of the lack of itch-sensing fibers and the NMB-NMBR-dependent itch pathway in the cornea offers an extra protective mechanism to prevent the cornea from becoming itchy. This newly described mechanism, combined with corneal supersensitivity, effectively protects the cornea from mechanical damages caused by scratching or rubbing.
The finding of conjunctiva-selective itch sensory fibers provides promising and unique neural targets for the development of new therapeutic strategies for antiocular itch. We provide proof of concept that silencing conjunctival itch-sensing fibers effectively alleviates ocular itch. This new therapeutic strategy is conceptually specific and is likely safe for the following reasons.
First, pharmacological silencing of conjunctival itch-sensing fibers exhibits a more sustained anti-itch effect than antihistamines currently used to treat ocular itch. In contrast to the binding of antihistamines to histamine receptors at the cell surface, the entry of QX-314 into conjunctival sensory fibers prevents the compound from being washed off by tear fluid and leads to sustained itch relief. Furthermore, silencing itch-sensing fibers reduces mast cell migration and accumulation at the allergen-challenged site and hence would decrease the amount of itch mediators released by mast cells, resulting in a less severe itch. This neuro-immune interaction offers a new explanation for the vicious cycle of itching and inflammation. Second, selective silencing of a highly restricted population of itchsensing afferent fibers in the conjunctiva circumvents common side effects, including dry eye, glaucoma, cataract and ocular infections, caused by antihistamines or immunosuppressive corticosteroids and cyclosporine. Finally, this strategy would not affect the function of other conjunctival sensory fibers or corneal sensory fibers, which regulate basal tearing and protect the integrity of ocular surface from potential injuries 49, 50 .
To develop new therapeutic strategies for allergic itch in humans, it is important to translate our discoveries from mice to humans. Despite the large size of the Mrgpr family in mice, there are only seven Mrgprs in humans. Interestingly, hMrgprX1 is sensitive to chloroquine and the peptide BAM8-22, both of which elicit histamine-independent itch in humans 25, 28, 51 . Our finding of selective projection of hMrgprX1-expressing sensory fibers to the conjunctiva, but not the cornea, in humans substantiates the pathogenic role of this population of neurons in ocular itch. Using MRGPRX1; Mrgpr-clusterΔ −/− mice, we confirmed the feasibility of pharmacological silencing of hMrgprX1 + sensory fibers using QX-314 for treating allergic ocular itch. Furthermore, we found that hMrgprX1 functions as a principal itch receptor in ocular allergy, suggesting that hMrgprX1 itself is a promising anti-itch drug target in addition to being a useful molecular marker for itch afferent fibers in the conjunctiva. It will be important to develop potent and specific antagonists of hMrgprX1 for itch management in the future. The humanized mouse model MRGPRX1; Mrgpr-clusterΔ −/− will facilitate pharmacological study of the anti-itch effects of hMrgprX1 antagonists in vivo and help yield key preclinical evidence.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41591-018-0083-x. All mice used for histology were anesthetized with ketamine-xylazine cocktail and transcardially perfused with ice-cold PBS followed by ice-cold 4% paraformaldehyde (PFA). Whole-mount corneal, oral mucosal, rectal, vaginal, conjunctiva, skin, and DRG tissues were dissected and imaged immediately using Nikon Ti-E microscope. Tissues used for frozen section were post-fixed in ice-cold PFA (4%, 0.5 h for the conjunctiva; 2%, 2 h for the skin; 3 h for the brain and 4%, 20 min for DRGs) and cryoprotected in 30% (wt/vol) sucrose-PBS solution for 24 h before they were embedded and frozen in OCT compound.
Tissues were sectioned at 20 μ m using a Leica CM-1950 cryostat, allowed to air dry for 1 h and washed using PBS containing 0.1% Triton-X 100 (PBST). Tissue sections carrying endogenous fluorescence were directly mounted using Fluoromount-G. Tissue sections that required staining were blocked using 10% normal goat serum for 1 h at room temperature and incubated in primary antibody at 4 °C overnight followed by secondary antibody at room temperature for 2 h. X-gal staining was performed according to the manufacturer's instructions. For mast cell staining, tissue sections were incubated with FITC or rhodamineconjugated avidin for 15 min at room temperature. After staining, tissue sections were mounted using Fluoromount-G and imaged after drying.
Retrograde labeling. WGA (1-2 µ L) was injected into the stroma of the cornea or the submucosa of the palpebral conjunctiva of anesthetized mice using pulled glass micropipettes. Animals were euthanized for tissue collection 48-60 h after the injections.
DiI (1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate) retrograde neuronal labeling was performed as previously described 18 . In short, ~0.5 µ L of 30 ng/µ L DiI were injected into the palpebral conjunctival of both lower eyelids of anesthetized mice using a glass micropipette. Animals were used for histology 5 d after DiI injection.
Cell picking. WGA-labeled trigeminal neurons were collected from adult mice (6-8 week old, both males and females) and pooled into DMEM-F12 medium supplemented with 10% FBS and antibiotics (DH10). Afterwards, DRGs were digested using a collagenase-dispase solution at 32 °C for 20 min, triturated, pelleted and resuspended in 400 µ l of DH10 medium per mouse. 200 µ l of the cell suspension was then carefully pipetted on top of 1.2 mL of freshly prepared 15% BSA in a 1.5-mL microcentrifuge tube and centrifuged at 400 g for 4 min to separate neurons from myelin and debris. After purification, the BSA supernatant was aspirated, and the pelleted neurons were resuspended in DH10 media. All steps after digestion were performed on ice.
Cells were isolated manually using a controlled cell-picking setup, constructed in-house around a Leica DMi6000 inverted epifluorescent microscope (Buffalo Grove, IL) and a Narishige MMO-202ND micromanipulator (Amityville, NY). WGA-labeled neurons were captured into pulled glass micropipettes with 20-µ m-wide openings and ejected into PCR tubes containing 10 µ l of lysis buffer and RNase inhibitor.
Real-time qRT-PCR. cDNA libraries from single neurons were generated using Invitrogen SuperScript III CellsDirect cDNA Synthesiss Kit (ThermoFisher, 18080300) and as previously described 25 . In short, manually isolated neurons were collected into 0.2-mL thin-walled PCR tubes prefilled with 10 µ L supplied lysis buffer and RNase inhibitor, flash frozen on dry ice and stored at − 80 °C until cDNA synthesis. DNase digestion was performed for all cells. First-strand cDNA was generated using 100 nmols (50 mM, 2 μ l) of oligo(dT) 20 . All other steps were performed according to the manufacturer's protocol.
qPCR was performed using power SYBR Green master mix (ABI 4368702) on an ABI StepOnePlus qPCR machine. Single-cell genomic DNA was used as the negative control and FACS-isolated DRG neurons (~36,000 neurons, diluted 1:36,000) were used as the positive control. Gapdh was used to identify and exclude samples without input or with failed cDNA synthesis. All primer sets were validated before use, and PCR products were selected for further sequence validation. All gene expression data is presented as folds of Gapdh expression, calculated using 2 -(Ct(target Gene) -Ct(Gapdh)) .
Behavioral assays. All animal behavioral experiments were performed and analyzed in a blinded manner. Ocular itch experiments were performed as described previously 18 . In short, 2-to 3-month-old mice were manually restrained, and 2.5 µ L of pruritogens were applied directly into the inferior conjunctival sac. Afterwards, animals were returned to recording chambers and filmed for 30 min. Scratch bouts directed at the treated conjunctiva were scored after completion of filming.
In the ocular cold pain tolerance assays, acclimated test animals were manually restrained, and a 0.5 L per min stream of temperature-controlled air was applied directly to the exposed corneas. Blinking, eye closure and other responses were quantified afterwards.
Mast cell-dependent allergy models were generated as described previously 18 . In short, mice were given two intraperitoneal (i.p.) injections of a 1:1 mixture of 0.01% (wt/vol) ovalbumin and Imject Alum 10 d apart to induce allergic sensitivity to OVA. Seven days after the second i.p. injection, sensitized animals were used for behavioral experiments and challenged with 250 μ g of ovalbumin to induce allergic ocular itch. To pharmacologically silence itch-sensing fibers in the conjunctiva, 2 μ l mixture solution (1% QX-314 + 4 mM chloroquine) was applied to the lower conjunctival sac of immunized mice before ovalbumin challenging. As a positive control, 0.4% pheniramine was used as a pretreatment to suppress histamine-dependent itch signaling in the conjunctiva. 10 min, 30 min, 1 h, 24 h or 48 h after pretreatments, mice were challenged with ovalbumin, video-recorded for 30 min and quantified blindly.
Mice used in the MrgprA3 + neuron ablation model were generated using a protocol adapted from previously published literature 18 . Two-month-old Mrgpra3 gfp-cre+ ; Rosa26 HBEGF/+ mice and Rosa26 HBEGF/+ control littermates were given two i.p. injections of 30 μ g per kg body weight diphtheria toxin (DTX) 3 d apart (HBEGF is the gene encoding diphtheria toxin receptor (DTR)). Treated animals were used for behavioral experiments 4 weeks after the second DTX injection.
Calcium imaging. Whole-mount calcium imaging of the conjunctiva was performed as described previously 18 . In short, conjunctivae were dissected and allowed to recover in oxygenated recording buffer at room temperature for 30 min. After recovery, dissected explants were imaged using a Nikon Ti-E inverted microscope and Photometrics CoolSnap HQ 2 CCD camera (Tucson, AZ). The responses of conjunctival sensory fibers to pruritogens were defined as changes in GCaMP3 fluorescence intensity (Δ F/F 0 ) using the Nikon NIS Elements AR software.
Calcium imaging of cultured DRG neurons was performed as described previously 25 . DRGs were collected from euthanized mice, aged 3-4 weeks, and pooled in DMEM-F12 medium supplemented with 10% FBS and antibiotics (DH10). Afterwards, DRGs were digested using a collagenase-dispase solution at 1 nature research | reporting summary
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The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistics including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)
For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted Our web collection on statistics for biologists may be useful.
Software and code
Policy information about availability of computer code
Data collection
Nikon NIS Elements AR software for calcium imaging data collection pCLAMP 10.5 software (Axon Instruments, U.S.) and Patchmaster software (v2; Heka Electronic) for electrophysiology data collection
Data analysis
Nikon NIS Elements AR software for calcium imaging data analysis pCLAMP 10.5 software (Axon Instruments, U.S.) and Patchmaster software (v2; Heka Electronic) for electrophysiology data analysis GraphPad Prism5 for statistical analysis For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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